SCHEMBL2525241

SCHEMBL2525241

CN(CC(O)c1ccc(OC(=O)c2ccccc2)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.51
ALDH1A1 P00352 1/20 0.51
PKM P14618 1/20 0.51
MAPT P10636 4/20 0.48
TDP1 Q9NUW8 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
PARP10 Q53GL7 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CACNA1B Q00975 2/20 0.39
MEN1 O00255 4/20 0.38
RAB9A P51151 1/20 0.38
BACE1 P56817 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2531804 0.93 ALDH1A1 (0.44) KMT2AALDH1A1PKMMAPTTDP1
SCHEMBL2528596 0.91 ALDH1A1 (0.42) KMT2AALDH1A1PKMMAPTTDP1
SCHEMBL2528599 0.91 ALDH1A1 (0.42) KMT2AALDH1A1PKMMAPTTDP1
SCHEMBL2532097 0.89 AOC3 (0.42) KMT2AALDH1A1PKMMAPTSLC6A2
SCHEMBL2525770 0.89 KMT2A (0.43) KMT2AALDH1A1PKMMAPTL3MBTL1
SCHEMBL2529638 0.89 KMT2A (0.41) KMT2AALDH1A1PKMMAPTTDP1
SCHEMBL2525522 0.89 MAPT (0.49) KMT2AALDH1A1PKMMAPTTDP1
SCHEMBL2531521 0.89 SLC6A2 (0.39) KMT2AALDH1A1PKMMAPTTDP1
SCHEMBL2532556 0.87 ALDH1A1 (0.41) KMT2AALDH1A1PKMMAPTSLC6A2
SCHEMBL2531401 0.87 ESR1 (0.46) KMT2AALDH1A1PKMMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039501-B2 Synephrine derivatives useful as anti-inflammatory agents UNIVERSITEIT GENT (BE) 2011-10-18 US disclosed
US-20090029999-A1 Synephrine derivatives useful as anti-inflammatory agents UNIVERSITEIT GENT (BE) 2009-01-29 US disclosed
EP-1963255-A1 SYNEPHRINE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS UNIVERSITEIT GENT (BE) 2008-09-03 EP disclosed
WO-2007071452-A1 SYNEPHRINE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS UNIVERSITEIT GENT (BE) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029999-A1 Synephrine derivatives useful as anti-inflammatory agents HRH1, HRH3, HRH2 KMT2A 2317/4885ALDH1A1 3248/4885PKM 3604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.